Stocks
Eloxx Pharmaceuticals, Inc.ELOX
NASDAQHealthcareBiotechnology$13.03
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing ribosome-targeting therapies for rare genetic diseases, including cystic fibrosis and other nonsense mutation disorders. Its lead candidate, ELX-02, is in Phase 2 trials, and the company's progress is closely watched by investors focused on orphan drug development.
52W Range: $8.20-$23.40
Congressional Interest in Eloxx Pharmaceuticals, Inc. (ELOX)
No congressional trades have been disclosed for Eloxx Pharmaceuticals, Inc. (ELOX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ELOX?
No congressional trades found for this stock.